Smita Pawar, Prashant Pingale, Atul Garkal, Riyaz Ali M Osmani, Kavita Gajbhiye, Madhur Kulkarni, Krutika Pardeshi, Tejal Mehta, Amarjitsing Rajput
Messenger RNA (mRNA) has gained marvelous attention for managing and preventing various conditions like cancer, Alzheimer's, infectious diseases, etc. Due to the quick development and success of the COVID-19 mRNA-based vaccines, mRNA has recently grown in prominence. A lot of products are in clinical trials and some are already FDA-approved. However, still improvements in line of optimizing stability and delivery, reducing immunogenicity, increasing efficiency, expanding therapeutic applications, scalability and manufacturing, and long-term safety monitoring are needed...
April 12, 2024: International Journal of Biological Macromolecules